CEFACLOR RAN

Land: Australien

Sprog: engelsk

Kilde: Department of Health (Therapeutic Goods Administration)

Aktiv bestanddel:

cefaclor monohydrate, Quantity: 393.36 mg (Equivalent: cefaclor, Qty 375 mg)

Tilgængelig fra:

Medis Pharma Pty Ltd

INN (International Name):

cefaclor monohydrate

Lægemiddelform:

Tablet, modified release

Sammensætning:

Excipient Ingredients: hypromellose; colloidal anhydrous silica; hyprolose; lactose monohydrate; purified talc; magnesium stearate; titanium dioxide; macrogol 400; indigo carmine aluminium lake; propylene glycol; purified water; isopropyl alcohol; iron oxide black

Indgivelsesvej:

Oral

Enheder i pakken:

10 tablets

Recept type:

(S4) Prescription Only Medicine

Terapeutiske indikationer:

For the treatment of the following infections caused by susceptible organisms, in adults and children 12 years and older: Lower respiratory infections, including community acquired pneumonia of mild to moderate severity (excluding atypical pneumonia), acute bronchitis and exacerbation of chronic bronchitis. Upper respiratory infections, including pharyngitis, tonsillitis and acute bacterial sinusitis. Symptomatic lower urinary tract infections, including cystitis. Skin and skin structure infections.

Produkt oversigt:

Visual Identification: Capsule shaped, biconvex, unscored, blue film-coated tablet, imprinted with "Cefaclor CD 375mg" in black.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 18 Months; Container Temperature: Store below 25 degrees Celsius

Autorisation status:

Licence status A

Autorisation dato:

2011-08-09